Development Of COVID-19 Vaccine Production During A Pandemic

This video shows how Agilent employees actively supported global pharmaceutical companies' COVID-19 vaccine production during the pandemic. In particular, Agilent's smooth cross-organizational collaboration with R&D, marketing, manufacturing, and logistics enabled quick fulfillment of urgent vaccine manufacturer requirements, supported by Agilent automated electrophoresis systems for reliable quality control of IVT RNA samples worldwide.